Kathryn Stecco, M.D., M.A.

Kathryn Stecco is a renowned medical technology entrepreneur, co-founder of Panthera Medtech. With over two decades of experience in domestic and international strategic planning, Kathryn has overseen Pre-clinical Research, Clinical Investigations, and Regulatory Submissions for 510(k), Premarket Approval (PMA), and CE marked medical products. Kathryn is a Medical Technology expert and possesses exceptional knowledge and experience with regards to the United States(FDA) and International regulations. Kathryn's expertise lies in International Council for Harmonisation (ICH) guidelines related to pharmacovigilance (PV), International Organization for Standardization (ISO) 14155 guidelines, safety monitoring and reporting in clinical trials, post-marketing surveillance, case processing, safety agreement standards, and reporting to Health Authorities worldwide. Kathryn has been part of multiple acquisitions - Panthera MedTech's Project Bengal, Nfocus Neuromedical, Inc., Lychron, LLC, Panthera MedTech's Project Cheetah, and LipoSonix, Inc.

Kathryn's educational background is also impressive. She has studied Medicine at Temple University - Lewis Katz School of Medicine, Stanford University's Department of Surgery, and has completed a Master's degree in Exercise Physiology from the University of Southern California. Kathryn holds M.D. in Medicine from the Keck School of Medicine of the University of Southern California.

Kathryn is the CEO and Co-Founder of Panther Orthopedics, Inc. She was also the Co-Founder and Chief Medical Officer at Panthera Medtech. Previously, she was the medical consultant at EndoShape, Inc., owner Concierge Medical Practice at Kathryn Stecco, M.D., Surgical Consultant at Mach Labs, L.P., Medical Consultant at Revance Therapeutics, Medical Director at EndoVx, Inc., and Vice President of Medical Affairs at Intrapace. Kathryn has demonstrated a thorough understanding of medical technology, clinical trials, post-market surveillance, and regulatory framework.